• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

妊娠肝内胆汁淤积症与母体血脂异常:系统评价和荟萃分析。

Intrahepatic cholestasis of pregnancy and maternal dyslipidemia: a systematic review and meta-analysis.

机构信息

Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, China.

Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China.

出版信息

Acta Obstet Gynecol Scand. 2022 Jul;101(7):719-727. doi: 10.1111/aogs.14380. Epub 2022 May 22.

DOI:10.1111/aogs.14380
PMID:35599353
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9564710/
Abstract

INTRODUCTION

The association between intrahepatic cholestasis of pregnancy (ICP) and maternal lipid metabolism remains unknown. This systematic review and meta-analysis aimed to evaluate the association between ICP and maternal lipid metabolism.

MATERIAL AND METHODS

We systematically searched Medline, Embase and the Cochrane Library (up to December 11, 2021) to identify relevant studies that investigated ICP and maternal plasma lipid concentrations. The weighted mean difference (WMD) and 95% confidence intervals (CI) were calculated using random-effects models. A subgroup analysis was conducted to identify the potential sources of heterogeneity. Potential publication bias was tested using funnel plots and the Egger's and Begg's tests. This meta-analysis was registered with PROSPERO (CRD42021293783).

RESULTS

Eleven studies were included in this qualitative analysis. A random-effects meta-analysis of data from the final included nine studies (n = 786 participants) showed a significant association between ICP and maternal dyslipidemia, with elevated levels of triglycerides (WMD, 0.67 mmol/L; 95% CI 0.39-0.95; P < 0.001), total cholesterol (WMD, 1.08 mmol/L; 95% CI 0.58-1.58; P < 0.001), low-density lipoprotein cholesterol (WMD, 1.08 mmol/L; 95% CI 0.53-1.64; P < 0.001), and reduced high-density lipoprotein cholesterol level (WMD, -0.38 mmol/L; 95% CI -0.53 to -0.23; P < 0.001) vs normal pregnancies.

CONCLUSIONS

The present study's findings support an association between ICP and maternal dyslipidemia. ICP pregnancies have dysregulated lipid metabolism vs normal pregnancies.

摘要

简介

妊娠肝内胆汁淤积症(ICP)与母体脂质代谢之间的关系尚不清楚。本系统评价和荟萃分析旨在评估 ICP 与母体脂质代谢之间的关系。

材料和方法

我们系统地检索了 Medline、Embase 和 Cochrane 图书馆(截至 2021 年 12 月 11 日),以确定调查 ICP 和母体血浆脂质浓度的相关研究。使用随机效应模型计算加权均数差(WMD)和 95%置信区间(CI)。进行亚组分析以确定潜在的异质性来源。使用漏斗图和 Egger 及 Begg 检验测试潜在的发表偏倚。本荟萃分析已在 PROSPERO(CRD42021293783)上注册。

结果

本定性分析纳入了 11 项研究。最终纳入的 9 项研究(n=786 名参与者)的数据进行随机效应荟萃分析显示,ICP 与母体血脂异常存在显著相关性,表现为甘油三酯水平升高(WMD,0.67mmol/L;95%CI,0.39-0.95;P<0.001)、总胆固醇(WMD,1.08mmol/L;95%CI,0.58-1.58;P<0.001)、低密度脂蛋白胆固醇(WMD,1.08mmol/L;95%CI,0.53-1.64;P<0.001)升高和高密度脂蛋白胆固醇水平降低(WMD,-0.38mmol/L;95%CI,-0.53 至-0.23;P<0.001)。

结论

本研究结果支持 ICP 与母体血脂异常之间存在关联。ICP 妊娠与正常妊娠相比,脂质代谢失调。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2122/9564710/61f0dd91aba5/AOGS-101-719-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2122/9564710/7be9a66a5301/AOGS-101-719-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2122/9564710/61f0dd91aba5/AOGS-101-719-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2122/9564710/7be9a66a5301/AOGS-101-719-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2122/9564710/61f0dd91aba5/AOGS-101-719-g001.jpg

相似文献

1
Intrahepatic cholestasis of pregnancy and maternal dyslipidemia: a systematic review and meta-analysis.妊娠肝内胆汁淤积症与母体血脂异常:系统评价和荟萃分析。
Acta Obstet Gynecol Scand. 2022 Jul;101(7):719-727. doi: 10.1111/aogs.14380. Epub 2022 May 22.
2
Gestational weight gain below instead of within the guidelines per class of maternal obesity: a systematic review and meta-analysis of obstetrical and neonatal outcomes.按孕妇肥胖类别划分,孕期体重增加未达而非处于指南范围:产科和新生儿结局的系统评价与荟萃分析
Am J Obstet Gynecol MFM. 2022 Sep;4(5):100682. doi: 10.1016/j.ajogmf.2022.100682. Epub 2022 Jun 18.
3
The relationship between social support and mental health problems during pregnancy: a systematic review and meta-analysis.妊娠期间社会支持与心理健康问题之间的关系:系统评价和荟萃分析。
Reprod Health. 2021 Jul 28;18(1):162. doi: 10.1186/s12978-021-01209-5.
4
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.减少或无麸质饮食对心血管疾病一级预防的影响。
Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2.
5
The effect of tamoxifen on the lipid profile in women: A systematic review and meta-analysis of randomized controlled trials.他莫昔芬对女性血脂谱的影响:一项随机对照试验的系统评价和荟萃分析。
Exp Gerontol. 2022 Mar;159:111680. doi: 10.1016/j.exger.2021.111680. Epub 2021 Dec 30.
6
The effect and safety of anacetrapib in the treatment of dyslipidemia: a systematic review and meta-analysis.阿那曲泊帕治疗血脂异常的疗效和安全性:一项系统评价和荟萃分析。
Postgrad Med. 2018 Jan;130(1):129-136. doi: 10.1080/00325481.2018.1401421. Epub 2017 Nov 14.
7
Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology.不明病因复发性流产女性预防流产的孕激素治疗
Cochrane Database Syst Rev. 2025 Jun 11;6(6):CD003511. doi: 10.1002/14651858.CD003511.pub6.
8
Effects of total fat intake on bodyweight in children.儿童总脂肪摄入量对体重的影响。
Cochrane Database Syst Rev. 2018 Feb 15;2(2):CD012960. doi: 10.1002/14651858.CD012960.
9
Effects of total fat intake on bodyweight in children.儿童总脂肪摄入量对体重的影响。
Cochrane Database Syst Rev. 2018 Jul 5;7(7):CD012960. doi: 10.1002/14651858.CD012960.pub2.
10
The effect of vitamin D on the lipid profile as a risk factor for coronary heart disease in postmenopausal women: a meta-analysis and systematic review of randomized controlled trials.维生素 D 对血脂谱的影响作为绝经后妇女冠心病的危险因素:一项荟萃分析和随机对照试验的系统评价。
Exp Gerontol. 2022 May;161:111709. doi: 10.1016/j.exger.2022.111709. Epub 2022 Jan 26.

引用本文的文献

1
Polymorphic Variants of Selected Genes Regulating Bile Acid Homeostasis in Women with Intrahepatic Cholestasis of Pregnancy.妊娠期肝内胆汁淤积症女性中调节胆汁酸稳态的特定基因的多态性变体
Int J Mol Sci. 2025 Aug 1;26(15):7456. doi: 10.3390/ijms26157456.
2
Genetic Insights Into Lipid Traits and Lipid-Modifying Drug Targets in Pregnancy Complications: A Two-Sample Mendelian Randomization Study.妊娠并发症中脂质特征和脂质修饰药物靶点的遗传见解:一项两样本孟德尔随机化研究
Int J Womens Health. 2025 Jan 31;17:221-234. doi: 10.2147/IJWH.S496268. eCollection 2025.
3
The severity of intrahepatic cholestasis of pregnancy and its association with pregnancy complications and neonatal asphyxia: A single-center case analysis and systematic review.

本文引用的文献

1
Influence of ursodeoxycholic acid therapy on levels of fibroblast growth factor 21, adiponectin and biochemical parameters in intrahepatic cholestasis of pregnancy.熊去氧胆酸治疗对妊娠肝内胆汁淤积症患者成纤维细胞生长因子21、脂联素水平及生化指标的影响
Clin Exp Hepatol. 2021 Mar;7(1):13-24. doi: 10.5114/ceh.2021.104419. Epub 2021 Mar 25.
2
Alterations of the Human Gut Microbiota in Intrahepatic Cholestasis of Pregnancy.妊娠肝内胆汁淤积症患者肠道微生物群的改变
Front Cell Infect Microbiol. 2021 Apr 30;11:635680. doi: 10.3389/fcimb.2021.635680. eCollection 2021.
3
Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a systematic review and individual participant data meta-analysis.
妊娠期肝内胆汁淤积症的严重程度及其与妊娠并发症和新生儿窒息的关系:一项单中心病例分析和系统评价。
Biomol Biomed. 2024 Oct 17;24(6):1501-1516. doi: 10.17305/bb.2024.10588.
4
Evaluation of alanine aminotransferase/aspartate aminotransferase ratio and high-density lipoprotein for predicting neonatal adverse outcomes associated with intrahepatic cholestasis of pregnancy.评估丙氨酸氨基转移酶/天冬氨酸氨基转移酶比值和高密度脂蛋白对预测与妊娠肝内胆汁淤积症相关的新生儿不良结局的作用。
PeerJ. 2024 Jun 24;12:e17613. doi: 10.7717/peerj.17613. eCollection 2024.
5
The impact of maternal intrahepatic cholestasis during pregnancy on the growth trajectory of offspring: a population-based nested case‒control cohort study.孕期母体肝内胆汁淤积症对后代生长轨迹的影响:基于人群的巢式病例对照队列研究。
BMC Pregnancy Childbirth. 2024 Jun 7;24(1):413. doi: 10.1186/s12884-024-06559-z.
6
Hepatoprotective agents in the management of intrahepatic cholestasis of pregnancy: current knowledge and prospects.妊娠期肝内胆汁淤积症治疗中的肝保护剂:当前认知与前景
Front Pharmacol. 2023 Aug 31;14:1218432. doi: 10.3389/fphar.2023.1218432. eCollection 2023.
7
Rational use of drugs to alleviate adverse outcomes caused by COVID-19 quarantine in women with intrahepatic cholestasis of pregnancy.合理用药以减轻妊娠肝内胆汁淤积症女性因新冠病毒隔离导致的不良后果。
Front Med (Lausanne). 2023 Aug 7;10:1122873. doi: 10.3389/fmed.2023.1122873. eCollection 2023.
8
Increased TG to HDL-C ratio is associated with severity of drug-induced liver injury.甘油三酯与高密度脂蛋白胆固醇比值升高与药物性肝损伤的严重程度相关。
Sci Rep. 2023 Apr 27;13(1):6897. doi: 10.1038/s41598-023-34137-4.
熊去氧胆酸治疗妊娠肝内胆汁淤积症:系统评价和个体参与者数据荟萃分析。
Lancet Gastroenterol Hepatol. 2021 Jul;6(7):547-558. doi: 10.1016/S2468-1253(21)00074-1. Epub 2021 Apr 27.
4
Intrahepatic cholestasis of pregnancy: Association with glycaemic control in gestational diabetes.妊娠期肝内胆汁淤积症:与妊娠期糖尿病血糖控制的关联
Diabet Med. 2021 Aug;38(8):e14574. doi: 10.1111/dme.14574. Epub 2021 Apr 7.
5
Pharmacological interventions for treating intrahepatic cholestasis of pregnancy.治疗妊娠期肝内胆汁淤积症的药物干预措施。
Cochrane Database Syst Rev. 2020 Jul 27;7(7):CD000493. doi: 10.1002/14651858.CD000493.pub3.
6
Ursodeoxycholic acid improves feto-placental and offspring metabolic outcomes in hypercholanemic pregnancy.熊去氧胆酸可改善胆汁淤积性妊娠的胎-胎盘和后代代谢结局。
Sci Rep. 2020 Jun 25;10(1):10361. doi: 10.1038/s41598-020-67301-1.
7
Intrahepatic Cholestasis in Pregnancy: Review of the Literature.妊娠期肝内胆汁淤积症:文献综述
J Clin Med. 2020 May 6;9(5):1361. doi: 10.3390/jcm9051361.
8
Association between intrahepatic cholestasis of pregnancy and risk of gestational diabetes and preeclampsia: a systematic review and meta-analysis.妊娠肝内胆汁淤积症与妊娠期糖尿病和子痫前期风险的关系:系统评价和荟萃分析。
Hypertens Pregnancy. 2020 Aug;39(3):354-360. doi: 10.1080/10641955.2020.1758939. Epub 2020 Apr 24.
9
Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy.胆汁酸受体 FXR 和 TGR5 在脂肪性肝病及其治疗中的作用。
Am J Physiol Gastrointest Liver Physiol. 2020 Mar 1;318(3):G554-G573. doi: 10.1152/ajpgi.00223.2019. Epub 2020 Jan 27.
10
Associations between Maternal Lipid Profiles and Pregnancy Complications: A Prospective Population-Based Study.母体脂质谱与妊娠并发症的相关性:一项前瞻性基于人群的研究。
Am J Perinatol. 2021 Jul;38(8):834-840. doi: 10.1055/s-0039-3402724. Epub 2019 Dec 31.